Delivery Order SPE2DB24D2013-SPE2DB25FCJGW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) on March 5, 2025, with a ceiling value of $2,115.16. This non-competitive, firm fixed price delivery order is set to be completed by March 6, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $4,639.13 to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) on August 27, 2025, with a completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single shipment of a combination antihypertensive medication to...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Telmisartan-Amlodipine 40-5 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order has a ceiling value of $3,017.64 and is scheduled for completion by August 13, 2025. The contract is unsolicited for set-aside programs and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count) on August 12, 2025, with a ceiling value of $1,344.82 and ultimate completion date of August 13, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) with a ceiling value of $1,939.39. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, completed on August 27, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for telmisartan-amlodipine 40-10mg tablets (30-count supply) valued at $3,501.35 under a firm fixed price contract. The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without any set-aside designation. This award represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,108.69 to AmerisourceBergen Drug Corp for the supply of Telmisartan-Amlodipine 40-10mg tablets (30-count) with a completion deadline of September 15, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 19, 2025, by the Defense Logistics Agency for the supply of Telmisartan-Amlodipine 40-5 mg tablets (30-count) with a ceiling value of $2,273.46. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,541.90 to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $5,501.84 to AmerisourceBergen Drug Corp for the supply of Telmisartan-Amlodipine 80-5 mg tablets in a quantity of 30 units. The contract, awarded on September 19, 2025, with an ultimate completion date of September 22, 2025, operates under firm fixed-price terms with no set-aside designation. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCJGWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Telmisartan-Amlodipine 80-10 mg tablets in a 30-count package. This $1,344.96 firm fixed price delivery order, without set-aside designation, is scheduled for completion by June 2, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a pediatric/adult combination antihypertensive pharmaceutical product delivery to support federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999, which extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, AmerisourceBergen Drug Corp leverages this comprehensive prime vendor vehicle to supply a broad range of generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded, non-set-aside delivery orders demonstrates its capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/30/25 |